Aurinia Pharmaceuticals Inc (AUPH)

Mar 03, 2026

Aurinia Pharmaceuticals (NASDAQ:AUPH) Director Buys $7,224,981.61 in Stock - MarketBeat

Mar 03, 2026

Mar 03, 2026

Aurinia Pharmaceuticals Inc (AUPH): Investor Outlook Reveals 19.63% Potential Upside - DirectorsTalk Interviews

Mar 03, 2026

Mar 03, 2026

Tang Capital LPs tied to Aurinia (NASDAQ: AUPH) buy 900K shares - Stock Titan

Mar 03, 2026

Mar 03, 2026

Tang Capital boosts Aurinia (AUPH) stake to 9.2% ownership - Stock Titan

Mar 03, 2026

Mar 03, 2026

Aurinia (NASDAQ: AUPH) CFO gets stock, options; covers tax bill - Stock Titan

Mar 03, 2026

Mar 03, 2026

Aurinia (AUPH) COO receives stock grants and settles taxes with shares - Stock Titan

Mar 03, 2026

Mar 03, 2026

Aurinia (NASDAQ: AUPH) CEO receives major option grant and withholds shares for taxes - Stock Titan

Mar 03, 2026

Mar 03, 2026

Aurinia (AUPH) CMO awarded new stock options and share grant - Stock Titan

Mar 03, 2026

Mar 03, 2026

Aurinia (AUPH) EVP gets stock awards and has shares withheld for taxes - Stock Titan

Mar 03, 2026

Mar 03, 2026

Aurinia Pharmaceuticals Inc (NASDAQ:AUPH) Passes Key Growth Screener from "The Little Book That Makes You Rich" - ChartMill

Mar 03, 2026

Mar 03, 2026

GSA Capital Partners LLP Trims Stake in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Mar 03, 2026

Mar 02, 2026

Should Aurinia’s Surging 2025 Earnings and Upbeat 2026 Outlook Require Action From Aurinia (AUPH) Investors? - Yahoo Finance

Mar 02, 2026

Mar 02, 2026

Aurinia’s LUPKYNIS Strength And Aritinercept Progress Versus Valuation Signals - Sahm

Mar 02, 2026

Mar 01, 2026

Aurinia Pharmaceuticals (AUPH) Reports Financial Results for Three and Twelve Months Ended December 31, 2025 - Bitget

Mar 01, 2026

Mar 01, 2026

Understanding the Setup: (AUPH) and Scalable Risk - Stock Traders Daily

Mar 01, 2026

Mar 01, 2026

12 Cheap Biotech Stocks to Buy Now - Insider Monkey

Mar 01, 2026

Feb 28, 2026

How Aurinia Pharmaceuticals Inc. stock trades during market volatilityWeekly Trade Review & AI Driven Stock Movement Reports - mfd.ru

Feb 28, 2026

Feb 27, 2026

Aurinia Pharmaceuticals Inc. (NASDAQ:AUPH) Q4 2025 Earnings Call Transcript - Insider Monkey

Feb 27, 2026

Feb 27, 2026

Aurinia Pharmaceuticals (AUPH) Earnings Spike Above Revenue Challenges Profit Quality Narratives - Sahm

Feb 27, 2026

Feb 27, 2026

Decoding Aurinia Pharmaceuticals Inc (AUPH): A Strategic SWOT In - GuruFocus

Feb 27, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Inc. Q4 2025 Earnings Call Summary - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals (NASDAQ:AUPH) Posts Earnings Results - MarketBeat

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals (AUPH) Stock Drops After Strong Quarter, Softer Forward Revenue Targets - Fidelity

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Q4 Earnings Call Highlights - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

AUPH: LUPKYNIS posted robust 2025 growth, with 2026 guidance reflecting continued momentum and market expansion - TradingView

Feb 26, 2026

Feb 26, 2026

Earnings call transcript: Aurinia Pharmaceuticals Q4 2025 earnings beat expectations - Investing.com

Feb 26, 2026

Feb 26, 2026

AUPH: LUPKYNIS sales and net income surged in 2025, with double-digit growth expected in 2026 - TradingView

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals : Corporate Presentation (Aurinia Corporate Presentation February 2026) - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Feb 26, 2026

Feb 26, 2026

Aurinia Results Highlight LUPKYNIS Momentum And New Aritinercept Growth Option - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

Earnings Breakdown: Aurinia Pharmaceuticals Q4 - Benzinga

Feb 26, 2026

Feb 26, 2026

Q4 2025 Earnings Call - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals (AUPH) Tops Q4 Earnings and Revenue Estimates - Yahoo Finance

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Inc. Provides Earnings Guidance for the Year 2026 - marketscreener.com

Feb 26, 2026

Feb 26, 2026

AUPH Stock Gains On Aurinia Pharma’s Q4 Beat, But 2026 Guidance Misses Estimates - Stocktwits

Feb 26, 2026

Feb 26, 2026

Aurinia Lifts Revenue on LUPKYNIS Growth, Sets Strong 2026 Sales Outlook - TipRanks

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Q4 Earnings, Revenue Rise; 2026 Revenue Outlook Set - marketscreener.com

Feb 26, 2026

Feb 26, 2026

AUPH: LUPKYNIS sales and net income soared in 2025, with strong growth and robust 2026 guidance - TradingView

Feb 26, 2026

Feb 26, 2026

Aurinia Lifts Profits on LUPKYNIS Growth and Sets Double-Digit 2026 Revenue Outlook - TipRanks

Feb 26, 2026

Feb 26, 2026

AURINIA PHARMACEUTICALS ($AUPH) Releases Q4 2025 Earnings - Quiver Quantitative

Feb 26, 2026

Feb 26, 2026

(AUPH) Aurinia Pharmaceuticals Expects Full Year 2026 Revenue Range $315M$325, vs. FactSet Est of $326.8M - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Earnings Flash (AUPH) Aurinia Pharmaceuticals Posts Q4 EPS $1.53 - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Earnings Flash (AUPH) Aurinia Pharmaceuticals Inc. Reports Q4 Revenue $77.1M, vs. FactSet Est of $74.7M - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Inc announces its financial results for the fourth quarter and full year ended December 31, 2025 - Bitget

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Inc. SEC 10-K Report - TradingView

Feb 26, 2026

Feb 26, 2026

Aurinia: Q4 Earnings Snapshot - marketscreener.com

Feb 26, 2026

Feb 26, 2026

Form 10-K Aurinia Pharmaceuticals For: Dec 31 - StreetInsider

Feb 26, 2026

Feb 26, 2026

Profit surge as Aurinia (NASDAQ: AUPH) raises 2026 LUPKYNIS outlook - Stock Titan

Feb 26, 2026

Feb 26, 2026

Earnings Summary: Aurinia Pharmaceuticals Q4 - Benzinga

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Reports Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provides Update on Recent Business Progress - marketscreener.com

Feb 26, 2026

Feb 26, 2026

BRIEF-Aurinia Pharmaceuticals Q4 Product Revenue USD 74.173 Million - TradingView

Feb 26, 2026

Feb 26, 2026

Aurinia Pharmaceuticals Inc (AUPH) Q4 2025 Earnings Call Highlights: Record Revenue Growth and ... By GuruFocus - Investing.com Canada

Feb 26, 2026

Feb 25, 2026

Earnings Preview: Aurinia Pharmaceuticals - Benzinga

Feb 25, 2026

Feb 25, 2026

Aurinia earnings on deck: Can lupus drug sustain growth momentum? By Investing.com - Investing.com Australia

Feb 25, 2026

Feb 24, 2026

Aurinia Pharmaceuticals (AUPH) Stock Analysis: A Look At Its 12.38% Potential Upside - DirectorsTalk Interviews

Feb 24, 2026

Feb 24, 2026

Aurinia Pharmaceuticals Inc expected to post earnings of 22 cents a shareEarnings Preview - TradingView

Feb 24, 2026

Feb 23, 2026

MSN Money - MSN

Feb 23, 2026

Feb 23, 2026

Aurinia (AUPH) COO has 32,901 shares withheld to cover RSU taxes - Stock Titan

Feb 23, 2026

Feb 23, 2026

Aurinia (AUPH) CEO Greenleaf has 100,171 shares withheld for RSU taxes - Stock Titan

Feb 23, 2026

Feb 23, 2026

Tax withholding trims Aurinia (AUPH) CFO stake by 32,424 shares - Stock Titan

Feb 23, 2026

Feb 23, 2026

[Form 4] Aurinia Pharmaceuticals Inc. Insider Trading Activity - Stock Titan

Feb 23, 2026

Feb 21, 2026

Jupiter Asset Management Ltd. Has $9.10 Million Stake in Aurinia Pharmaceuticals Inc $AUPH - MarketBeat

Feb 21, 2026

Feb 19, 2026

Aurinia Sets February 26 Date to Report 2025 Results and Business Update - TipRanks

Feb 19, 2026

Feb 19, 2026

Aurinia Pharmaceuticals Inc (AUPH) has announced that it will release its financial results for the fourth quarter and full year ended December 31, 2025, on February 26, 2026. - Bitget

Feb 19, 2026

Feb 19, 2026

Aurinia Pharmaceuticals to Report Financial Results for the Three and Twelve Months Ended December 31, 2025 and Provide Update on Recent Business Progress on February 26, 2026 - ChartMill

Feb 19, 2026

Feb 19, 2026

Aurinia Pharmaceuticals (AUPH) Projected to Post Quarterly Earnings on Thursday - MarketBeat

Feb 19, 2026